Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App




Mindray Showcases Hematology Innovations at ISLH 2022

By LabMedica International staff writers
Posted on 27 Sep 2022

Mindray (Shenzhen, China) showcased its hematology innovations and academic achievements to medical experts from Europe and around the world at the International Symposium on Technological Innovations in Laboratory Hematology (ISLH 2022) held between September 8-10 in Bologna, Italy. More...

Held annually, the symposium serves as an international platform where the latest technology, new ideas and research findings in laboratory hematology are showcased and shared.

At ISLH 2022, Mindray held a seminar titled "The New Era of Digital Morphology", where Prof. Gina Zini and Prof. Anna Merino, two renowned experts in morphology, presented an evaluation of the performance of its MC-80 digital cell morphology analyzer in detecting onco-hematological diseases by referring to special clinical cases, and how it can help doctors screen and diagnose malignant and non-malignant blood diseases, respectively through high-resolution blood cell images. During the ISLH poster session, 32 posters from Mindray's hematology end-users were presented after stringent evaluation based on unique insights and exceptional academic values, outnumbering all other exhibitors. At its ISLH 2022 booth, Mindray showcased its new MC-80 digital cell morphology analyzer and the BC-700 series hematology analyzer, which attracted much interest from visitors. Mindray's academic strength was also recognized by the ISLH committee which granted the company the "Berend Houwen Travel Award" for outstanding contributions to the industry and excellence in academics.

Before ISLH, Mindray attracted over 700 participants to the HemaTalk Italy 2022 Global Live Event. Dr. Ramon Simon-Lopez from Mindray IVD Scientific Research and Medical Affairs, noted that the company has been utilizing its global resources to build a learning and exchange platform for global medical experts and empower the future of laboratory medicine. The attendees held an online conversation with Mindray’s R&D team to discuss the future of laboratory hematology and the latest trends in translating clinical research results into practice. A Q&A session followed where the attendees had their most important questions answered by Mindray’s experts.

Related Links:
Mindray 


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.